Introduction
============

Models of evolutionary change, particularly at the molecular level, tend to focus on the effects of mutation, natural selection, and genetic drift operating on genes one at a time. But molecular evolution is actually generated by the manner in which fitness differences at the level of the whole organism are mapped to and from the DNA sequence level via development and physiology. These mapping functions are usually represented in the form of genetic networks. A fundamental question in the field is therefore whether patterns of molecular evolution are best understood by taking the global network context of the genes of interest into account or whether taking a locus-by-locus approach is sufficient. A systematic way of examining the distribution of selective pressure in genetic networks is to investigate the relationship between network structure and nucleotide variation of individual genes interacting within those networks. Large-scale studies in major cellular networks have shown that network topology does indeed affect the rate of protein evolution. Specifically, central and highly connected proteins in the metabolic and protein--protein interaction networks tend to evolve more slowly than proteins at network peripheries ([@bib14]; [@bib19]; [@bib47]; [@bib34]). However, central transcription factors tend to evolve faster in the yeast gene regulatory network, despite a similar network topology, suggesting that the distribution of selective pressure within networks depends more specifically on the function of the network under study ([@bib27]). Thus, it is important to compare the pattern of nucleotide variation in multiple networks in order to ascertain whether or not it is possible to generate general rules for molecular evolution within genetic networks.

Investigation of nucleotide variation in the context of linear metabolic pathways has been particularly informative for addressing this question because the patterns can be interpreted within the context of population genetic models of metabolic flux ([@bib28]). Theory predicts that upstream enzymes in linear pathways will evolve greater control over metabolic fluxes and will 1) preferentially fix beneficial mutations during adaptive walks and 2) be under stronger purifying selection as optimal control is reached in the population ([@bib53]). Analysis of nucleotide divergence in the anthocyanin pathway in plants supports the prediction that downstream enzymes experience relaxed selection and evolve faster than upstream enzymes ([@bib39], [@bib38]; [@bib35]). Similar effects of pathway position on nucleotide variation have been shown for the melanin synthesis pathway in silkworms ([@bib58]) as well as the carotenoid ([@bib33]) and terpenoid ([@bib37]) biosynthetic pathways in plants.

It remains unclear, however, whether a similar pattern is to be expected for different types of linear pathways. In signal transduction pathways, for instance, one might expect evolutionary changes to be concentrated in the upstream receptor because receptors interact with the "external" environment, whereas downstream elements might be expected to be under stronger purifying selection because they are located within a more stable cytoplasmic milieu. For example, analysis of the human-signaling network shows that purifying selection increases as a function of cellular localization, from the extracellular space to the nucleus ([@bib10]). However, detailed analyses of various signal transduction pathways in several organisms have revealed heterogeneity in the relationship between the nucleotide rate variation and the position of a gene within the pathway. All potential outcomes appear possible, as these studies have found no relationship to pathway structure ([@bib26]), a trend similar to that observed in metabolic pathways in which the most upstream genes evolve more slowly ([@bib40]), and an inverse polarity in which the most downstream genes tend to be more conserved ([@bib2], [@bib3]; [@bib54]).

The insulin-signaling (IS) pathway is particularly well suited for addressing this set of questions. It is well characterized and largely functionally conserved across a broad phylogenetic swath including yeast, flies, nematodes, rodents, and humans ([@bib15]; [@bib5]; [@bib8]). Mutations affecting IS in these organisms have similar phenotypic effects on lifespan, oxidative-stress resistance, lipid storage, and metabolism. The pathway is most famously characterized in *Caenorhabditis elegans*, as mutations in many pathway components can lead to a many-fold increase in lifespan ([@bib29]). Here ([fig. 1*A*](#fig1){ref-type="fig"}), upon activation of the AAP-1 adaptor subunit and the phosphotidylinositol 3-OH kinase subunit AGE-1 by the insulin/IGF-1 receptor DAF-2, AGE-1 converts PIP~2~ into PIP~3~ which then recruits the serine/threonine kinases PDK-1, AKT-1, AKT-2, and SGK-1 to the cell membrane. The kinases phosphorylate and control the localization of the transcription factor FOXO/DAF-16 and prevent its entry in the nucleus thereby down-regulating transcription of stress--response genes ([fig. 1*A*](#fig1){ref-type="fig"}). Mutations in these factors prevent this phosphorylation and therefore generate constitutive stimulation of the stress--response pathway, which subsequently increases individual lifespan. The IS pathway also interacts with other conserved pathways including the Tor, Ras, JNK, and TGF-β pathways ([@bib44]). Investigations of the impact of pathway structure on nucleotide divergence in the insulin/Tor-signaling pathway in Drosophila and vertebrates consistently reveal that they show the reverse-polarity situation, with downstream proteins tending to evolve more slowly than upstream proteins ([@bib2], [@bib3]). Is the same pattern of nucleotide variation within functionally conserved pathways expected among distantly related organisms, and if so, will these similar trends be the result of the same or different underlying biological mechanisms?

![(*A*) Activation of the IS pathway negatively regulates the transcription factor DAF-16 by preventing its entry in the nucleus. The IS pathway interacts with multiple signal transduction pathways. Redrawn following ([@bib44]), with modifications to include additional interactions specified in [@bib23] and [@bib9]. (*B*) Linear graph of the insulin/Tor pathway used to investigate the impact of the pathway structure on nucleotide divergence. Here, we focus on proteins that mediate signal transduction in response to stimuli detected by the insulin receptor DAF-2.](gbeevr071f01_ht){#fig1}

Here, we examine these questions by investigating nucleotide divergence in Caenorhabditis in the context of the structure of the insulin/Tor-signaling pathway. We find the global pattern of nucleotide substitution to be similar to that seen in Drosophila and vertebrates but that differences in the rate of evolution at synonymous sites suggest that the underlying causes of this pattern are likely to be different. Understanding the relationship between network structure and rates of molecular evolution is therefore likely to depend on a more detailed understanding of the genotype--phenotype map than is revealed by the topology of the genetic network per se.

Materials and Methods
=====================

The Insulin/Tor Pathway in *C.* *elegans*
-----------------------------------------

The pattern of interactions among the *C. elegans* insulin/Tor-signaling pathway genes was obtained from several recent review and research articles ([fig. 1*A*](#fig1){ref-type="fig"}) ([@bib23]; [@bib22]; [@bib36]; [@bib4]; [@bib7]; [@bib43]; [@bib8]; [@bib9]; [@bib44]). Within this larger network, we examined nucleotide divergence focusing on proteins that mediate signal transduction in response to stimuli detected by the insulin receptor DAF-2 ([fig. 1*B*](#fig1){ref-type="fig"}) in order to investigate how the structure of the insulin/Tor pathway affects protein evolution in nematodes, flies, and vertebrates ([@bib2], [@bib3]). We assigned the first position in the pathway to DAF-2 and we counted the number of steps from DAF-2 to determine each protein\'s position within the pathway ([table 1](#tbl1){ref-type="table"}).

###### 

Summary of Nucleotide Divergence and Gene Variables Used in the Multivariate Analysis

  Gene        *Caenorhabditis briggsae*--*Caenorhabditis* sp. 9 Comparisons   *C. briggsae*--*Caenorhabditis remanei* Comparisons                                                                                  
  ----------- --------------------------------------------------------------- ----------------------------------------------------- -------- -------- ------ -------- -------- -------- --------- ------ --------- ---
  *daf-2*     3909                                                            0.0348                                                0.3717   0.0936   4656   0.3093   3.4522   0.0896   50.9835   1552   1.99375   1
  *ist-1*     2997                                                            0.0093                                                0.3073   0.0301   2901   0.1688   2.9045   0.0581   52.5675   967    2.2875    2
  *aap-1*     1566                                                            0.0052                                                0.1218   0.0428   1539   0.1896   3.2266   0.0588   50.6140   513    NA        3
  *age-1*     3546                                                            0.0030                                                0.1780   0.0170   3513   0.1867   2.0769   0.0899   50.6090   1171   2.825     3
  *pdk-1*     1863                                                            0.0218                                                0.1746   0.1248   1854   0.2544   4.3497   0.0585   51.6825   618    4         4
  *akt-1*     1596                                                            0.0099                                                0.1442   0.0684   1596   0.0856   1.6772   0.0511   50.1770   532    11.25     5
  *sgk-1*     1362                                                            0.0126                                                0.1216   0.1039   1359   0.0456   1.8861   0.0242   50.7925   453    7.1375    5
  *daf-16*    1584                                                            0.0019                                                0.0817   0.0226   1557   0.0570   0.7504   0.0759   49.0960   519    12.425    6
  *daf-15*    2148                                                            0.0156                                                0.3051   0.0510   5325   0.1033   1.9296   0.0535   49.9820   1775   2.725     7
  *let-363*   7617                                                            0.0032                                                0.2283   0.0142   7734   0.0847   1.5645   0.0541   48.9230   2578   7.475     7
  *rsks-1*    1332                                                            0.0051                                                0.0982   0.0517   1617   0.0416   1.1936   0.0348   48.6305   539    NA        8
  *pha-4*     1197                                                            0.0183                                                0.1427   0.1279   1191   0.0956   1.1403   0.0838   48.8010   397    9.5875    9
  *hif-1*     2415                                                            0.0058                                                0.1508   0.0387   2154   0.0997   0.8055   0.1238   53.9200   718    20.8875   9

Note.---*N* : number of sites analyzed after gaps were removed, ENC: effective number of codons, L: protein length.

Identification of Orthologs and Phylogenetic Analyses
-----------------------------------------------------

*C. elegans* orthologs of the insulin/Tor-signaling genes were identified in the *Caenorhabditis briggsae* ([@bib45]), *Caenorhabditis japonica*, *Caenorhabditis brenneri*, *Caenorhabditis remanei*, *Caenorhabditis* sp. 7, *Caenorhabditis* sp. 9, and *Caenorhabditis* sp. 11 (Genome Sequencing Center, Washington University, St. Louis, unpublished data) genome assemblies using the TBlastN program ([@bib1]). For each gene, we identified only one similar sequence with two exceptions: no clear ortholog of *akt-2* could be identified in any of the genome assemblies and two highly similar sequences of *let-363* were found in *C. brenneri*, consistent with ∼30% of the *C. brenneri* genes having two alleles in the genome assembly ([@bib6]; [@bib25]). We combined exons from the two *Cbn-let-363* alleles because of incomplete sequence for one allele and sequencing errors in the second allele. Intron/exon boundaries were predicted relative the *C. elegans* protein sequence. Some sequences are incomplete due to the fragmented and preliminary nature of the genome assemblies.

Protein sequences were aligned by eye using BioEdit ([@bib20]) and subsequently used to generate codon-based DNA sequence alignments. Sequence alignments are available upon request. Phylogenetic reconstruction for each orthologous group (single-gene analysis) was obtained with MrBayes ([@bib42]) applying a JTT model of protein sequence evolution ([@bib24]). Parameter space was searched with four independent runs of 1,000,000 generations each and with four chains. Trees were samples every 100 generations and posterior probabilities were determined after discarding the first 2,500 trees ("burn-in"). We also sought to infer the phylogenetic relationships among the eight Caenorhabditis species using a similar analysis based on concatenated sequences of the insulin/Tor genes. In this analysis, parameter space was searched with four independent runs of 10,000 generations with the same tree sampling frequency and also applying a 25% burn-in. Half of the single-gene analyses (6/13) gave a well supported topology, identical to the one retrieved with the concatenated sequences ([fig. 2](#fig2){ref-type="fig"}), and corresponding to the known relationship among the named species ([@bib31]; [@bib30]). Topologies obtained during the other single-gene analyses (7/13) either have poorly supported nodes or conflict with the accepted species tree ([@bib31]; [@bib30]), and only two were identical. In subsequent codon-based tests of selection, we used the topology obtained with the concatenated sequences ([fig. 2](#fig2){ref-type="fig"}) and when the single-gene topology was different, we used the topology that best fits the data according to model M0 (see below). Only single-gene topologies for *daf-15*, *pdk-1*, *pha-4*, and *sgk-1* were used after comparing alternative topologies with the likelihood ratio test (LRT).

![Phylogenetic relationships among *Caenorhabditis* species obtained using Bayesian inference with concatenated protein sequences from 13 insulin/Tor-signaling genes. The posterior probability at each node is 1.](gbeevr071f02_lw){#fig2}

Codon-Based Sequence Analyses
-----------------------------

Maximum likelihood estimates of the rates of nonsynonymous (d*N*) and synonymous (d*S*) substitutions along with the corresponding ratio (ω) were computed between *C. briggsae* and *C. remanei* and between *C. briggsae* and *Caenorhabditis* sp. 9 with the CODEML program in PAML 3.14 ([@bib56]) with model M0, which provides a single estimate of across all sites and lineages. To test for positive selection acting on the insulin/Tor pathway genes, we used an LRT between models M7 and M8 ([@bib57]) and obtained significance of the likelihood ratio statistic *2Δl* by comparison to the χ^2^ distribution with 2 degrees of freedom. Models M7 and M8 allow ω to vary among sites according to a beta distribution, estimated with 10 categories, and model M8 has an additional parameter ω \> 1. To determine if ω is significantly greater than 1, we compared model M8a in which ω = 1 with model M8 ([@bib46]) using an LRT with 1 degree of freedom. We also performed an LRT with 1 degree of freedom between models M1a and M2a ([@bib50]). Model M1a allows 2 classes of sites with ω \< 1 and ω = 1, respectively, and model M2a has a third class of sites with ω \> 1. For all codon-based analyses, ambiguous sites were removed, no molecular clock was assumed, and codon frequencies were estimated from the observed nucleotide frequencies at each codon position.

Gene-Level Variables
--------------------

In our investigation of the effect of pathway structure on nucleotide divergence, we also examined the possible confounding effects of several other variables including protein length, codon bias, and expression level. We determined the correlation among variables using Spearman\'s rank correlation. Protein length is the length of the protein in pairwise alignments between *C. remanei* and *C. briggsae* after gaps were removed. Codon bias is the average effective number of codons (ENC) ([@bib52]) between *C. remanei* and *C. briggsae* orthologs. ENC values were obtained for each orthologous gene with DnaSp 5.10 ([@bib32]). Expression level is the average expression measured in *C. elegans* with microarrays at eight time points spanning embryonic development and adulthood ([@bib21]). We also tested the effect of expression level on nucleotide divergence at each separate time point and obtained qualitatively similar results (not shown). Expression level is missing for *aap-1* and *rsks-1*.

Results
=======

The Rate of Nucleotide Substitution Decreases along the Insulin/Tor Pathway
---------------------------------------------------------------------------

The rate of nonsynonymous changes between *C. briggsae* and *C. remanei* orthologs varies 7.5-fold among the IS genes ([table 1](#tbl1){ref-type="table"}). We tested if the position of a protein within the insulin/Tor pathway could impact the rate of protein sequence evolution and explain the observed variability among IS genes. Variability in nonsynonymous changes is strongly negatively correlated with the position of a protein in the pathway (Spearman\'s ρ = −0.638, *P* = 0.018). The more downstream proteins tend to evolve more slowly ([fig. 3](#fig3){ref-type="fig"}), similar to the pattern observed along the insulin/Tor pathway in Drosophila ([@bib2]) and in vertebrates ([@bib3]).

![Nucleotide substitution is strongly affected by the position of a gene in the insulin/Tor pathway because of increasing purifying selection associated to expression level differences. The rates of nonsynonymous (*A*) and synonymous (*B*) changes are negatively correlated with the position of a gene in the insulin/TOR pathway. However, there is no correlation between and pathway position (*C*). Expression level is strongly correlated with pathway structure and downstream genes tend to be expressed at higher levels (*D*).](gbeevr071f03_lw){#fig3}

This pattern of natural selection could result either from a tendency of the upstream genes to be under positive selection or from increasing purifying selection operating along the pathway. To test between these alternatives, we performed codon-based tests of selection using orthologs from eight Caenorhabditis species. A first LRT favored model M8 ([@bib57]), a model allowing a proportion of sites to evolve under positive selection, for 7 of the 13 genes. Nevertheless, a second LRT showed that ω for this class of sites is significantly greater than 1 for only 1 gene, *pha-4*, located downstream in the pathway. Moreover, comparisons of nearly neutral and positive selection models M1a and M2a ([@bib50]) failed to detect any instance of positive selection ([table 2](#tbl2){ref-type="table"}). These results suggest that the observed pattern of variation along the insulin pathway is unlikely to result predominantly from positive selection acting on the upstream genes but may instead be accounted for by increasing levels of purifying selection.

###### 

Results of codon-based tests of selection

              lnL (M7)   lnL (M8)   *2*Δ*l* (M7--M8)   lnL (M8a)   *2*Δ*l* (M8a--M8)   lnL (M1a)   lnL (M2a)   *2*Δ*l* (M1a--M2a)
  ----------- ---------- ---------- ------------------ ----------- ------------------- ----------- ----------- --------------------
  *daf-2*     −18114.3   −18109.4   9.8\*\*            −18109.2    −0.4                −18270.7    −18270.7    0
  *ist-1*     −9983.3    −9983.3    0                  −9982.6     −1.4                −10102.3    −10102.3    0
  *aap-1*     −8665      −8663.8    2.4                −8663.1     −1.4                −8755.8     −8755.8     0
  *age-1*     −16719.2   −16716.3   5.8                −16716.3    0                   −16877      −16877      0
  *pdk-1*     −9340.4    −9340.4    0                  −9340.3     −0.2                −9484.1     −9484.1     0
  *akt-1*     −7645.6    −7641.4    8.4\*              −7641.4     0                   −7720.9     −7720.9     0
  *sgk-1*     −5581.9    −5581.1    1.6                −5581.1     0                   −5634.1     −5634.1     0
  *daf-16*    −3889.9    −3888.7    2.4                −3888.7     0                   −3916.17    −3916.17    0
  *daf-15*    −9030.7    −9025.9    9.6\*              −9025.9     0                   −9114       −9114       0
  *let-363*   −26832.9   −26824.8   16.2\*\*\*         −26824.8    0                   −27076.8    −27076.8    0
  *rsks-1*    −5170      −5170      0                  −5170       0                   −5194.4     −5194.4     0
  *pha-4*     −5293.9    −5289.2    9.4\*\*            −5293.1     7.8\*               −5356.7     −5356.7     0
  *hif-1*     −8984.8    −8980.9    7.8\*              −8980.9     0                   −9020.1     −9020.1     0

LRTs were performed between models M7 and M8, models M8 and M8a and between models M1a and M2a. The LRTs do not show evidence of rampant positive selection acting on the IS genes. With the exception of *pha-4*, ω is not significantly greater than 1 for genes with the best fitting model allowing a proportion of site to evolve under position selection. \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001.

If mutations in the IS genes have different pleiotropic effects, causing selective constraints to be distributed along the insulin/Tor pathway, then we would expect this effect to manifest itself on d*N* and ω but not on d*S*. However, d*S* is not randomly distributed along the insulin pathway ([fig. 3](#fig3){ref-type="fig"}) but instead strongly correlates negatively with the position of a protein in the pathway (Spearman\'s ρ = −0.815, *P* \< 0.001). In contrast, ω is not correlated (Spearman\'s ρ = −0.088, *P* = 0.774). The strong polarity of d*S* along the pathway and the lack of correlation for ω further suggest that positive selection is unlikely to be a major determinant in the distribution of nucleotide rate divergence and point to increasing levels of purifying selection affecting both d*N* and d*S*. Moreover, pleiotropic constraints due to the cumulative effect of mutations in the insulin/Tor and/or interacting pathways cannot be the sole cause underlying this pattern of selection because such selective constraints would be expected to affect protein sequence evolution only.

In Drosophila and vertebrates, the structure of the insulin/Tor pathway affects the rate of protein sequence evolution but does not seem to have much impact on d*S* ([@bib2], [@bib3]). *C. briggsae* and *C. remanei* have diverged long enough such that saturation at synonymous sites could complicate inferences based on d*S* and ω. Therefore, we also estimated nucleotide divergence from another species pair, *C. briggsae* and *Caenorhabditis* sp. 9. These two species split in the recent past, as reflected by their ability to produce fertile hybrid progeny ([@bib51]), and do not show saturation at synonymous sites ([table 1](#tbl1){ref-type="table"}). The architecture of the insulin pathway has the same effects using these estimates of nucleotide divergence. Both d*N* (Spearman\'s ρ = −0.149, *P* = 0.627) and d*S* (Spearman\'s ρ = −0.423, *P* = 0.150) are negatively correlated with pathway position whereas is not correlated (Spearman\'s ρ = 0.066, *P* = 0.830). Although the correlations are not significant, they are qualitatively similar to those obtained using *C. briggsae* and *C. remanei*. The lack of significance is presumably due to the short divergence time between *C. briggsae* and *Caenorhabditis* sp. 9 and subsequently the lower variance in nucleotide substitution rate among IS genes in this species pair. For instance, the standard deviations for d*N* and d*S* are, respectively, 8 and 12 times lower among *C. briggsae* and *Caenorhabditis* sp. 9 orthlogs than among *C. briggsae* and *C. remanei* orthologs. Overall, then, the effect of pathway position on sequence evolution is not dependent upon the choice of species used to compute nucleotide rate divergence, and nucleotide variation is distributed differently along the insulin pathway in nematodes, flies, and vertebrates.

The Pattern of Selective Constraints along the Insulin/Tor Pathway Is Driven by Differential Expression Level
-------------------------------------------------------------------------------------------------------------

Because pleiotropic constraint cannot account for the observed pattern of selection along the insulin pathway, we tested if this pattern could be due to the distribution of one or several variables affecting purifying selection ([@bib41]). Specifically, we tested if the position in the pathway is correlated with expression level, codon bias, and protein length. Protein length (Spearman\'s ρ = −0.188, *P* = 0.539) and codon bias (Spearman\'s ρ = -0.505, *P* = 0.078) do not correlate significantly with pathway position (although the latter is nonetheless fairly negative). However, the level of gene expression in *C. elegans* is strongly correlated with the position that a gene occupies in the pathway ([fig. 3*D*](#fig3){ref-type="fig"}; Spearman\'s ρ = 0.714, *P* = 0.0136). Rates of synonymous and nonsynonymous changes are reduced in highly expressed genes, respectively, because of selection for translational accuracy and selection for translational robustness ([@bib11]). Using *C. elegans* expression as a proxy for other species, rates of nucleotide divergence are highly dependent upon expression level for the IS genes, whether they are measured using *C. briggsae* and *C. remanei* (d*N*: Spearman\'s ρ = −0.664, *P* = 0.026; d*S*: Spearman\'s ρ = −0.864, *P* \< 0.001) or *C. briggsae* and *Caenorhabditis* sp. 9 (d*N*: Spearman\'s ρ = −0.454, *P* = 0.160; d*S*: Spearman\'s ρ = −0.791, *P* = 0.004).

Although variation in expression level provides a strong predictor of evolutionary rate in this system, each of the functional variables are correlated with one another, making it impossible to completely isolate their effects. We did not find a significant residual correlation between pathway position and nucleotide divergence after removing the effect of expression level (d*N*: Spearman\'s ρ = −0.467, *P* = 0.148; d*S*: Spearman\'s ρ = −0.471, *P* = 0.143), although the pattern is still negative, and the limited number of pathway components seriously limits the power of a multivariate analysis. Nevertheless, the high dependence of d*S* on expression level and pathway position, which in particular is not expected to be a direct effect of pathway structure, and the absence of correlation between ω and pathway position both strongly argue that expression level has a large influence on evolutionary rates and that the contribution of pathway structure on protein evolution, if any, is likely to be small relative to the effect of expression level.

Altogether, these results suggest that the pattern of nucleotide variation along the insulin pathway is driven by gene expression level rather than by pleiotropic constraints or increased purifying selection in the downstream elements in relation to their function in mediating the cellular response. Moreover, these results point to the need to consider possible confounding variables when analyzing the relationship between pathway structure and evolutionary rates. Importantly, different factors explain the polarity of purifying selection along the well-conserved insulin/Tor pathway in nematodes, flies, and vertebrates ([@bib2], [@bib3]), suggesting that the effect of the position of gene within a pathway on protein sequence evolution is largely specific to the broader functional context of the pathway under study.

Discussion
==========

We found that the rate of amino acid replacements correlates negatively with the position of a protein in the insulin/Tor-signaling pathway in Caenorhabditis ([fig. 3](#fig3){ref-type="fig"}), similar to the pattern observed in several other signal transduction pathways including the insulin/Tor pathway in Drosophila and vertebrates ([@bib2], [@bib3]; [@bib10]; [@bib54]). One possible explanation is that evolutionary changes may preferentially localize to the receptor in signal transduction pathways because such changes have the potential to affect the entire system and/or that more downstream components may be under stronger purifying selection because they are required to transduce the signal in the cell. Interestingly, the insulin-like receptor DAF-2 is the most divergent protein in the pathway ([table 1](#tbl1){ref-type="table"} and [fig. 3](#fig3){ref-type="fig"}). It is conceivable that modifications at the ligand--receptor interaction may reflect adaptation to changing conditions and may play a role in the distribution of selective constraints in signal transduction pathways. Consistent with this interpretation, recent analyses found evidence of adaptive evolution in the insulin receptor and some of its ligands in Drosophila ([@bib17], [@bib18]) and a global analysis of human-signaling pathways shows that purifying selection increases from the extracellular space to the nucleus ([@bib10]).

However, a major difference among nematodes, flies, and vertebrates is that selection on synonymous changes is also distributed along the insulin/Tor pathway in worms, while ω does not vary with pathway position ([fig. 3](#fig3){ref-type="fig"}). Moreover, in Caenorhabditis, the distribution of purifying selection along the pathway seems to be predominantly the result of the tendency of downstream genes to be expressed at higher levels. The high dependence of both d*N* and d*S* on expression level is consistent with the translational robustness and accuracy hypotheses ([@bib11]) and is not easily reconciled by the hypothesis of selection pressure acting to maintain the function of downstream signal transduction elements or with pleiotropic constraints in relation to the interaction with other pathways. In Drosophila and vertebrates, the pattern of selection on protein evolution remains after correcting for the effect of gene expression and codon usage ([@bib2], [@bib3]). Thus, our results clearly show that the pattern of nucleotide variation can differ among functionally conserved pathways and that the underlying biological causes can also be different.

Previously, we found that the relationship between nucleotide variation and network topology can also be different in large cellular networks sharing similar topological properties ([@bib27]). These results and those presented here strongly suggest that any rules that govern the evolution of interacting proteins, if they exist, are unlikely to be functions of network structure per se. It is therefore somewhat remarkable that investigations of nucleotide variation in linear metabolic pathways in various organisms do in fact tend to find the same pattern of polarity of selective pressure ([@bib39], [@bib38]; [@bib35]; [@bib33]; [@bib37]; [@bib58]). In this case, an explicit population genetic model grounded in metabolic flux control theory is available to help predict the effect of the position of a gene on protein evolution ([@bib53]). Similarly, predictions for the pattern of selection acting on branch point enzymes in metabolic networks based on metabolic flux control ([@bib12]) have thus far been supported by the available data ([@bib48]; [@bib13]; [@bib16]; [@bib55]). The challenge ahead is to build explicit functional models for different types of pathways (including signal transduction pathways), similar to those developed for metabolic pathways ([@bib53]), in order to understand the conditions under which natural selection may operate within pathways and networks. This is the framework required to move from anecdotal reports of nucleotide variation among interacting genes to a more predictive network-centered view of natural selection ([@bib49]).

We thank the Genome Institute at Washington University School of Medicine in St. Louis for releasing unpublished genome sequences and providing the research community with this tremendous resource. This work was supported by grants from the National Science Foundation (DEB-0710378) and the Ontario Ministry of Research and Innovation to R.J. and by grants from the National Institutes of Health (R03-AG029377 and P01-AG022500 to P.C.P.).

[^1]: **Associate editor:** Michael Purugganan
